Effect of the COVID-19 Pandemic on Monitoring and Control of Cardiovascular Risk Factors and Disparities

• Yuan Lu, ScD,
• John E. Brush, Jr, MD,
• Yuntian Liu, MPH,
• Shu-Xia Li, PhD,
• Jordan R. Asher, MD, MS,
• Harlan M. Krumholz, MD, SM

Affiliations

Yuan Lu, ScD

Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut; Section of Cardiovascular Medicine, Department of Internal Medicine, New Haven, Connecticut

John E. Brush, Jr, MD

Sentara Health Research Center, Sentara Health, Norfolk, Virginia; Eastern Virginia Medical School, Norfolk, Virginia; Sentara Health and Eastern Virginia Medical School, 350 Centre Pointe Drive, Virginia Beach, Virginia 23462-4415, USA.

Yuntian Liu, MPH

Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut

Shu-Xia Li, PhD

Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut

Jordan R. Asher, MD, MS

Sentara Health Research Center, Sentara Health, Norfolk, Virginia

Harlan M. Krumholz, MD, SM

Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut; Section of Cardiovascular Medicine, Department of Internal Medicine, New Haven, Connecticut; Department of Health Policy and Management, Yale School of Medicine, New Haven, Connecticut